Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,200.3
27.3 (0.86%)

 

  • STI Straits Times Index
    3,200.3
    27.3 (0.86%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,587.5
    9.1 (0.58%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,610.7
    -26.8 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,418.9
    -22.4 (-0.65%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,357.8
    26.5 (0.09%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,928.3
    -41.9 (-0.70%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,799.6M
  • Value: 1,479.4M
  • Rise: 165
  • Fall: 169
  • Unch: 435

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.008-
Renaissance United0.003+0.001
ESR-REIT0.390-0.020
Sembcorp Marine0.198-0.002
SPH1.520-0.270
Jiutian Chemical0.100+0.001
VCPlus0.032-0.001
Blumont0.005-
MM2 Asia0.063-
YZJ Shipbldg SGD1.530+0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,752.2 +119.4
HSI 28,610.7 -26.8
HSCEI 10,699.0 -57.4
Jakarta 5,928.3 -41.9
Nikkei 225 29,357.8 +26.4
SSE Comp 3,418.9 -22.4
Shanghai A 3,583.5 -23.5
Shanghai B 248.2 -0.4
KOSPI 3,197.2 +18.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

LKL LKL INTERNATIONAL BERHAD
Quotes 15 Minutes Delayed. Updated at 07 May 2021 16:59
Last (MYR): 0.365 Change: +0.030 High: 0.370 Remarks:
Change (%): +8.96 Low: 0.335
Open 0.335 Yesterday's Close 0.335
Buy Price 0.365 Sell Price 0.370
Buy Volume ('00) 24,700 Sell Volume ('00) 15,642
Cumulative Volume ('00) 640,976 Cumulative Value 22,605,048
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.00835 Trailing EPS (MYR) e 0.00675 NAV (MYR) b 0.2352
PE a 43.713 Trailing PE f 54.094 Price / NAV b 1.5519
Dividend (MYR) d - Cash In Hand (MYR) g 0.1063 Issued & Paid-up Shares c 514,560,000
Dividend Yield (%) d - Price / Cash In Hand g 3.434 Treasury Shares h -
Beta - 75 Daysi 1.876 R-Squared - 75 Days(%)i 1.92 Market Cap (M) 187.814
Beta - 500 Daysi 2.254 R-Squared - 500 Days (%)i 6.39 Enterprise Value (M) 141.524
Piotroski F Score 5 Exchange Code 0182 Par Value ( $ ) n.a.
52 Weeks Volatility (%) 122.88 6-Month VWAP 0.481 Free Float (%) 60.9
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 Apr 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 14 Apr 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference LKL Bursa 187.814 43.713 54.094 1.5519 -
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 6,717.884 25.795 7.602 5.6463 1.671
Medical Specialties Bursa 17,711.487 32.555 7.976 6.1112 1.382
Index BM HEALTH CARE Bursa 9,479.499 36.307 11.691 3.6223 1.324
Local Peer TOPGLOV Bursa 42,227.585 24.094 6.134 6.1723 2.277
Local Peer HARTA Bursa 33,146.814 76.443 17.614 7.9251 0.791
Local Peer SUPERMX Bursa 12,740.911 24.278 5.493 3.9253 -
Local Peer RGTBHD Bursa 254.309 51.181 18.821 2.4559 -
Global Peer ABBOTT LABORATORIES NYSE 210,723.494 47.110 36.995 6.2786 1.286
Global Peer DANAHER CORP NYSE 184,368.356 52.527 52.527 4.9627 0.278
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 184,108.814 28.880 23.234 5.2516 0.190
Global Peer MEDTRONIC PLC NYSE 170,800.469 35.665 59.060 3.3650 1.759
Global Peer INTUITIVE SURGICAL INC NASDAQ 101,490.598 95.692 86.493 9.9956 -
Global Peer STRYKER CORP NYSE 95,987.855 60.030 68.173 7.1092 0.923
Global Peer BECTON DICKINSON & CO NYSE 69,619.160 90.768 46.167 2.8230 1.333
Global Peer BOSTON SCIENTIFIC CORP NYSE 61,267.028 - 428.441 - -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 57,296.282 69.585 67.328 12.2995 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 53,278.379 39.374 39.374 3.6684 1.755
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), AGILENT TECHNOLOGIES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALCON AG (NYSE), DEXCOM INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), RESMED INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), NOVOCURE LTD (NASDAQ), COOPER COS INC (NYSE), WATERS CORP (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), HOLOGIC INC (NASDAQ), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), MICROPORT (HKEx), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), Top Glove (SGX), WEIGAO GROUP (HKEx), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), SOTERA HEALTH CO (NASDAQ), STAAR SURGICAL CO (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), QUIDEL CORP (NASDAQ), NEOGEN CORP (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), CARDIOFLOW-B (HKEx), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), CONMED CORP (NYSE), LIVANOVA PLC (NASDAQ), CAREDX INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), VENUS MEDTECH-B (HKEx), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), ATRICURE INC (NASDAQ), HAEMONETICS CORP (NYSE), INMODE LTD (NASDAQ), VERICEL CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), AXONICS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), PEIJIA-B (HKEx), LIFETECH SCI (HKEx), HESKA CORP (NASDAQ), BUTTERFLY NETWORK INC (NYSE), AVANOS MEDICAL INC (NYSE), KANGJI MEDICAL (HKEx), SILK ROAD MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), AK MEDICAL (HKEx), EARGO INC (NASDAQ), PULMONX CORPORATION (NASDAQ), INOGEN INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), NANO-X IMAGING LTD (NASDAQ), 908 DEVICES INC (NASDAQ), NANOSONICS LIMITED (ASX), MESA LABORATORIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), CRYOLIFE INC (NYSE), CIRC (HKEx), ATRION CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SI BONE INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CERUS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), CHUNLI MEDICAL (HKEx), DERMTECH INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), AXOGEN INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANGIODYNAMICS INC (NASDAQ), BASECARE-B (HKEx), NATUS MEDICAL INC (NASDAQ), VIEWRAY INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), BIOVENTUS INC (NASDAQ), SURMODICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), KDL MEDICAL (HKEx), CUTERA INC (NASDAQ), ZYNEX INC (NASDAQ), VAPOTHERM INC (NYSE), STEREOTAXIS INC (NYSE American), MODERN DENTAL (HKEx), NEUROPACE INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), PULSE BIOSCIENCES INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), SIENTRA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), Medtecs Intl (SGX), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), QUOTIENT LTD (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), SOLITON INC (NASDAQ), ONCOCYTE CORP (NASDAQ), PAVMED INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), IRADIMED CORP (NASDAQ), NEURONETICS INC (NASDAQ), YESTAR HEALTH (HKEx), MISONIX INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CORMEDIX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), UGHealthcare (SGX), DARIOHEALTH CORP (NASDAQ), INVACARE CORP (NYSE), AROA BIOSURGERY LTD (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), CYCLOPHARM LIMITED (ASX), INTRICOM CORP (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), OPTISCAN IMAGING (ASX), TELA BIO INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), VINCENT MED (HKEx), APOLLO ENDOSURGERY INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CONFORMIS INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PW MEDTECH (HKEx), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), KELFRED (HKEx), IMPEDIMED LIMITED (ASX), SOMNOMED LIMITED (ASX), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALPHA PRO TECH (NYSE American), IRIDEX CORP (NASDAQ), FONAR CORP (NASDAQ), MICRO-X LTD (ASX), CLEANSPACE HOLDINGS LTD (ASX), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), BIOLASE INC (NASDAQ), APPLIED UV INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), VENUS CONCEPT INC (NASDAQ), CELSION CORPORATION (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ZOSANO PHARMA CORP (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), MILESTONE SCIENTIFIC INC (NYSE American), ELECTROMED INC (NYSE American), SDI LTD (ASX), LENSAR INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), IMMUCELL CORP (NASDAQ), NEPHROS INC (NASDAQ), ELECTROCORE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), DELCATH SYSTEMS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESPIRI LTD (ASX), COMPUMEDICS (ASX), NEOVASC INC (NASDAQ), YUNNAN ENERGY (HKEx), SENSUS HEALTHCARE INC (NASDAQ), Biolidics (SGX), STRATA SKIN SCIENCES INC (NASDAQ), BIOMERICA INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), CARDIEX LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DIMERIX LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), INSPIREMD INC (NYSE American), DAXOR CORP (NYSE American), SINTX TECHNOLOGIES INC (NASDAQ), LIFE HEALTHCARE (HKEx), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RESAPP HEALTH LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), TENAX THERAPEUTICS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), NUWELLIS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ADHERIUM LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), NANOVIBRONIX INC (NASDAQ), TRUSCREEN GROUP LTD (ASX), OBALON THERAPEUTICS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), CYANOTECH CORP (NASDAQ), METALICITY LIMITED (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), USCOM LTD (ASX), DYNATRONICS CORP (NASDAQ), Yunnan Energy (SGX), STAR EQUITY HOLDINGS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), Annica (SGX), NEUROMETRIX INC (NASDAQ), ANALYTICA (ASX), DORSAVI LTD (ASX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.025
+7.35 %
10 Days -+0.035
+10.61 %
20 Days --0.010
-2.67 %
Medium Term Return 3 Months --0.435
-54.38 %
6 Months --0.705
-65.89 %
1 Year --0.015
-3.95 %
Long Term Return 2 Years -+0.260
+247.62 %
3 Years -+0.220
+151.72 %
Annualised Return Annualised --
+36.03 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.270 - 2.020 Change From 1 Year Low +0.095 % Change From 1 Year Low (%) +35.19
Change From 1 Year High -1.655 % Change From 1 Year High (%) -81.93
2 Years Range 0.085 - 2.020 Change From 2 Years Low +0.280 % Change From 2 Years Low (%) +329.41
Change From 2 Years High -1.655 % Change From 2 Years High (%) -81.93
5 Years Range 0.085 - 2.020 Change From 5 Years Low +0.280 % Change From 5 Years Low (%) +329.41
Change From 5 Years High -1.655 % Change From 5 Years High (%) -81.93
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

IPO Performance

Listing Date 16 May 2016 Full Subscription Rate (x) -
No of Placement Shares (M) 42.00 No of Public Offer Shares (M) 113.00 Public Offer Subscription Rate (x) -
IPO Price (MYR) 0.200 First Day Close (MYR) 0.280 First Week Close (MYR) 0.275
Current vs IPO Price (%) +82.50 First Day Gain (%) +40.00 First Week Gain (%) +37.50

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Apr 2019 Part 1(2.46 MB)
Annual Report 2018 Apr 2018 Part 1(0.48 MB)
Part 2(1.53 MB)
Part 3(0.96 MB)
Part 4(0.35 MB)
Annual Report 2017 Apr 2017 Part 1(2.81 MB)
Annual Report 2016 Apr 2016 Part 1(0.08 MB)
Part 2(2.13 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
07 May 2021 0.335 0.370 0.335 0.365 64,097,600 0.3527
06 May 2021 0.355 0.355 0.325 0.335 50,920,400 0.3377
05 May 2021 0.380 0.390 0.350 0.355 61,000,000 0.3732
04 May 2021 0.390 0.405 0.370 0.375 148,312,900 0.3871
03 May 2021 0.350 0.415 0.350 0.385 342,882,400 0.3907
30 Apr 2021 0.330 0.345 0.325 0.340 30,504,000 0.3338
28 Apr 2021 0.335 0.340 0.325 0.330 20,341,200 0.3290
27 Apr 2021 0.360 0.365 0.335 0.335 54,153,200 0.3468
26 Apr 2021 0.335 0.360 0.335 0.350 132,813,900 0.3495
23 Apr 2021 0.335 0.355 0.330 0.330 65,267,500 0.3418
22 Apr 2021 0.305 0.355 0.300 0.330 165,094,200 0.3301
21 Apr 2021 0.305 0.320 0.300 0.300 63,314,700 0.3076
20 Apr 2021 0.300 0.320 0.290 0.300 68,435,100 0.3040
19 Apr 2021 0.320 0.320 0.300 0.300 54,796,400 0.3078
16 Apr 2021 0.340 0.360 0.315 0.315 125,659,500 0.3332
15 Apr 2021 0.360 0.385 0.340 0.340 299,013,100 0.3664
14 Apr 2021 0.365 0.405 0.350 0.355 152,907,900 0.3755
13 Apr 2021 0.405 0.410 0.355 0.360 49,057,100 0.3763
12 Apr 2021 0.385 0.435 0.380 0.400 143,543,700 0.4145
09 Apr 2021 0.440 0.450 0.350 0.375 196,736,700 0.3985
08 Apr 2021 0.290 0.465 0.290 0.450 476,358,900 0.4109
07 Apr 2021 0.280 0.300 0.270 0.285 16,874,300 0.2888
Summary
Current 2 Weeks
(23 Apr 2021 to 07 May 2021)
0.335 0.415 0.325 0.365 970,293,100 -
Previous 2 Weeks
(09 Apr 2021 to 22 Apr 2021)
0.440 0.450 0.325 0.330 1,318,558,400 -
4 Weeks from
(12 Mar 2021 to 08 Apr 2021)
0.410 0.415 0.325 0.450 1,148,843,000 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.